738 related articles for article (PubMed ID: 3005412)
1. Interleukin 2 (IL 2) up-regulates its own receptor on a subset of human unprimed peripheral blood lymphocytes and triggers their proliferation.
Harel-Bellan A; Bertoglio J; Quillet A; Marchiol C; Wakasugi H; Mishall Z; Fradelizi D
J Immunol; 1986 Apr; 136(7):2463-9. PubMed ID: 3005412
[TBL] [Abstract][Full Text] [Related]
2. The role of interleukin 2 and T11 E rosette antigen in activation and proliferation of human NK clones.
Schmidt RE; Hercend T; Fox DA; Bensussan A; Bartley G; Daley JF; Schlossman SF; Reinherz EL; Ritz J
J Immunol; 1985 Jul; 135(1):672-8. PubMed ID: 3923116
[TBL] [Abstract][Full Text] [Related]
3. Effects of natural and recombinant IL 2 on regulation of IFN gamma production and natural killer activity: lack of involvement of the Tac antigen for these immunoregulatory effects.
Ortaldo JR; Mason AT; Gerard JP; Henderson LE; Farrar W; Hopkins RF; Herberman RB; Rabin H
J Immunol; 1984 Aug; 133(2):779-83. PubMed ID: 6203980
[TBL] [Abstract][Full Text] [Related]
4. TCGF (IL 2)-receptor inducing factor(s). I. Regulation of IL 2 receptor on a natural killer-like cell line (YT cells).
Yodoi J; Teshigawara K; Nikaido T; Fukui K; Noma T; Honjo T; Takigawa M; Sasaki M; Minato N; Tsudo M
J Immunol; 1985 Mar; 134(3):1623-30. PubMed ID: 2578514
[TBL] [Abstract][Full Text] [Related]
5. In vitro maturation of B cells in chronic lymphocytic leukemia. I. Synergistic action of phorbol ester and interleukin 2 in the induction of Tac antigen expression and interleukin 2 responsiveness in leukemic B cells.
Kabelitz D; Pfeffer K; von Steldern D; Bartmann P; Brudler O; Nerl C; Wagner H
J Immunol; 1985 Oct; 135(4):2876-81. PubMed ID: 2993419
[TBL] [Abstract][Full Text] [Related]
6. IL 2 receptor induction on human T lymphocytes: role for IL 2 and monocytes.
Wakasugi H; Bertoglio J; Tursz T; Fradelizi D
J Immunol; 1985 Jul; 135(1):321-7. PubMed ID: 2987347
[TBL] [Abstract][Full Text] [Related]
7. Natural killer cells activated by interleukin 2 treatment in vivo respond to interleukin 2 primarily through the p75 receptor and maintain the p55 (TAC) negative phenotype.
Weil-Hillman G; Voss SD; Fisch P; Schell K; Hank JA; Sosman JA; Sugamura K; Sondel PM
Cancer Res; 1990 May; 50(9):2683-91. PubMed ID: 1691679
[TBL] [Abstract][Full Text] [Related]
8. IL 2 alone is mitogenic only for Tac-positive lymphocytes in human peripheral blood.
Taylor DS; Kern JA; Nowell PC
J Immunol; 1986 Mar; 136(5):1620-4. PubMed ID: 3005396
[TBL] [Abstract][Full Text] [Related]
9. Characteristics of the IL-2 receptor expressed on large granular lymphocytes from patients with abnormally expanded large granular lymphocytes. Implication of a non-Tac IL-2-binding peptide.
Hori T; Uchiyama T; Onishi R; Kamio M; Umadome H; Tamori S; Motoi T; Kodaka T; Uchino H
J Immunol; 1988 Jun; 140(12):4199-203. PubMed ID: 2836509
[TBL] [Abstract][Full Text] [Related]
10. Mechanisms by which accessory cells contribute in growth of resting T lymphocytes initiated by OKT3 antibody.
Palacios R
Eur J Immunol; 1985 Jul; 15(7):645-51. PubMed ID: 3924633
[TBL] [Abstract][Full Text] [Related]
11. Human T lymphocyte activation by monoclonal antibodies; OKT3, but not UCHT1, triggers mitogenesis via an interleukin 2-dependent mechanism.
Van Wauwe JP; Goossens JG; Beverley PC
J Immunol; 1984 Jul; 133(1):129-32. PubMed ID: 6327822
[TBL] [Abstract][Full Text] [Related]
12. IL-2 receptors on circulating natural killer cells and T lymphocytes. Similarity in number and affinity but difference in transmission of the proliferation signal.
Ben Aribia MH; Moiré N; Métivier D; Vaquero C; Lantz O; Olive D; Charpentier B; Senik A
J Immunol; 1989 Jan; 142(2):490-9. PubMed ID: 2783438
[TBL] [Abstract][Full Text] [Related]
13. Direct activation of human resting T cells by IL 2: the role of an IL 2 receptor distinct from the Tac protein.
Bich-Thuy LT; Dukovich M; Peffer NJ; Fauci AS; Kehrl JH; Greene WC
J Immunol; 1987 Sep; 139(5):1550-6. PubMed ID: 3040856
[TBL] [Abstract][Full Text] [Related]
14. Lymphokine-activated killer cells in rats: analysis of progenitor and effector cell phenotype and relationship to natural killer cells.
Vujanovic NL; Herberman RB; Olszowy MW; Cramer DV; Salup RR; Reynolds CW; Hiserodt JC
Cancer Res; 1988 Feb; 48(4):884-90. PubMed ID: 3257412
[TBL] [Abstract][Full Text] [Related]
15. Proliferation of phenotypically immature human thymocytes with and without interleukin 2 receptors.
Piantelli M; Larocca LM; Aiello FB; Maggiano N; Carbone A; Ranelletti FO; Musiani P
J Immunol; 1986 May; 136(9):3204-10. PubMed ID: 3082982
[TBL] [Abstract][Full Text] [Related]
16. Interleukin-2 receptor (Tac antigen) expressed on adult T cell leukemia cells.
Uchiyama T; Hori T; Tsudo M; Wano Y; Umadome H; Tamori S; Yodoi J; Maeda M; Sawami H; Uchino H
J Clin Invest; 1985 Aug; 76(2):446-53. PubMed ID: 2993359
[TBL] [Abstract][Full Text] [Related]
17. Production of B cell growth factor by a Leu-7+, OKM1+ non-T cell with the features of large granular lymphocytes (LGL).
Pistoia V; Cozzolino F; Torcia M; Castigli E; Ferrarini M
J Immunol; 1985 May; 134(5):3179-84. PubMed ID: 3920315
[TBL] [Abstract][Full Text] [Related]
18. Effects of anti-Tac antibody on the response of large granular lymphocytes to interleukin-2.
Mukaida N; Kasahara T; Hosoi J; Shioiri-Nakano K; Kawai T
Immunology; 1986 Jan; 57(1):137-43. PubMed ID: 3002967
[TBL] [Abstract][Full Text] [Related]
19. Suppression of interleukin 2 receptor acquisition by monoclonal antibodies recognizing the 50 KD protein associated with the sheep erythrocyte receptor on human T lymphocytes.
Reed JC; Tadmori W; Kamoun M; Koretzky G; Nowell PC
J Immunol; 1985 Mar; 134(3):1631-9. PubMed ID: 2981917
[TBL] [Abstract][Full Text] [Related]
20. A soluble interleukin 2 receptor produced by a normal alloreactive human T cell clone binds interleukin 2 with low affinity.
Jacques Y; Le Mauff B; Boeffard F; Godard A; Soulillou JP
J Immunol; 1987 Oct; 139(7):2308-16. PubMed ID: 2821110
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
